Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry
Lisa J. Deesker(Emma Kinderziekenhuis), Justine Bacchetta(Université Claude Bernard Lyon 1), Jérôme Harambat(Bordeaux Population Health), Michiel J.S. Oosterveld(Emma Kinderziekenhuis), Georges Deschênes(Hôpital Robert-Debré), Larisa Prikhodina(Pirogov Russian National Research Medical University), Asheeta Gupta(Birmingham Women’s and Children’s NHS Foundation Trust), Rezan Topaloğlu(Hacettepe University), Laure Collard(Centre Hospitalier Chrétien), Pierre Cochat(Société Nationale des Chemins de Fer Français (France)), Giorgia Mandrile(University of Turin), Bernd Höppe(University of Bonn), Bodo B. Beck(University of Cologne), Sander F. Garrelfs(Emma Kinderziekenhuis), Sally‐Anne Hulton(Birmingham Children's Hospital), Jaap W. Groothoff(University of Amsterdam), Thomas J. Neuhaus(University of Zurich), Eduardo Salido(Universidad de La Laguna)
Cited by 18
Related Papers
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505
History, epidemiology and regional diversities of urolithiasis
|Pediatric Nephrology|2008|460
SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1–SIX1–DNA complexes
|Proceedings of the National Academy of Sciences|2004|420